Family Calls on FDA to Allow Access to ‘Revolutionary’ Cancer Drug

March 24, 2008 01:41 PM
by findingDulcinea Staff
The Loughmans hope that raising public awareness will convince the government to relax regulations on the release of the pancreatic cancer drug TNFerade.

30-Second Summary

The Loughman family will hold a news conference Monday in an attempt to garner support for their efforts to make TNFerade available to pancreatic cancer patients, such as wife and mother Connie Loughman and actor Patrick Swayze.

A press release about the event says the pancreatic cancer-fighting drug, made by the biotechnology firm GenVec, should be made available to patients suffering from the deadly disease, which kills 90 percent of patients within one year of being diagnosed.

“Well-meaning, but misguided, regulations have tied the hands of the FDA and the biotechnology firm, GenVec, from providing access to the only drug shown to cure the disease,” according to the release.

But the drug is still under trial and currently unavailable for public use.

The GenVec Web site states that the drug is in a “Phase III” trial stage, and provides links with further information for those who want to learn more about the trial.

The National Cancer Institute
states that there will be an estimated 37,680 new cases of pancreatic cancer in the United States in 2008, and 34,290 people will die from the disease.

Headline Links: Family works for cancer-fighting treatment

Related Topics: GenVec

Support for patients

Reference: The facts on pancreatic cancer


Most Recent Beyond The Headlines